AAAAAA
Results:
1-23
|
Results: 23
Authors:
Shimono, M
Hiraki, A
Ueoka, H
Tanimoto, Y
Aoe, M
Sakae, K
Kaneda, K
Sakugawa, M
Kiura, K
Harada, M
Citation: M. Shimono et al., Successful treatment with concurrent chemoradiotherapy followed by surgeryfor a patient with thymic adenocarcinoma, ANTICANC R, 21(4A), 2001, pp. 2519-2522
Authors:
Hiraki, A
Ono, T
Tanaka, M
Kiura, K
Ueoka, H
Kawai, H
Harada, M
Nakayama, E
Noguchi, Y
Citation: A. Hiraki et al., Generation of cytotoxic T lymphocytes against autologous lung cancer cellsresistant to apoptosis, ANTICANC R, 21(4A), 2001, pp. 2561-2567
Authors:
Fujimoto, N
Hiraki, A
Ueoka, H
Harada, M
Citation: N. Fujimoto et al., Metastasis to the penis in a patient with squamous cell carcinoma of the lung with a review of reported cases, LUNG CANC, 34(1), 2001, pp. 149-152
Authors:
Shibayama, T
Ueoka, H
Nishii, K
Kiura, K
Tabata, M
Miyatake, K
Kitajima, T
Harada, M
Citation: T. Shibayama et al., Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC), LUNG CANC, 32(1), 2001, pp. 61-69
Authors:
Ueoka, H
Tanimoto, M
Kiura, K
Tabata, M
Takigawa, N
Segawa, Y
Takata, I
Eguchi, K
Okimoto, N
Harita, S
Kamei, H
Shibayama, T
Watanabe, Y
Hiraki, S
Harada, M
Citation: H. Ueoka et al., Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group, BR J CANC, 85(1), 2001, pp. 9-13
Authors:
Maeda, T
Ueoka, H
Tabata, M
Kiura, K
Shibayama, T
Gemba, K
Takigawa, N
Hiraki, A
Katayama, H
Harada, M
Citation: T. Maeda et al., Prognostic factors in advanced non-small cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis, JPN J CLIN, 30(12), 2000, pp. 534-541
Authors:
Takigawa, N
Segawa, Y
Ueoka, H
Kiura, K
Tabata, M
Shibayama, T
Takata, I
Miyamoto, H
Eguchi, K
Harada, M
Citation: N. Takigawa et al., Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer, CANC CHEMOT, 46(4), 2000, pp. 272-278
Authors:
Bessho, A
Tabata, M
Kiura, K
Takata, I
Nagata, T
Fujimoto, N
Kunisada, K
Ueoka, H
Harada, M
Citation: A. Bessho et al., Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by reverse transcriptase-polymerase chain reaction, ANTICANC R, 20(2B), 2000, pp. 1149-1154
Authors:
Fujimoto, N
Hiraki, A
Ueoka, H
Kiura, K
Bessho, A
Takata, I
Hiramatsu, Y
Ikeda, K
Harada, M
Citation: N. Fujimoto et al., Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer, LUNG CANC, 30(2), 2000, pp. 145-148
Authors:
Gemba, K
Ueoka, H
Kiura, K
Tabata, M
Harada, M
Citation: K. Gemba et al., Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome, LUNG CANC, 29(1), 2000, pp. 23-31
Authors:
Mimoto, J
Kiura, K
Matsuo, K
Yoshino, T
Takata, I
Ueoka, H
Kataoka, M
Harada, M
Citation: J. Mimoto et al., (-)-epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice, CARCINOGENE, 21(5), 2000, pp. 915-919
Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity:A pharmacogenetic analysis
Authors:
Ando, Y
Saka, H
Ando, M
Sawa, T
Muro, K
Ueoka, H
Yokoyama, A
Saitoh, S
Shimokata, K
Hasegawa, Y
Citation: Y. Ando et al., Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity:A pharmacogenetic analysis, CANCER RES, 60(24), 2000, pp. 6921-6926
Authors:
Segawa, Y
Ueoka, H
Kiura, K
Kamei, H
Tabata, M
Sakae, K
Hiraki, Y
Kawahara, S
Eguchi, K
Hiraki, S
Harada, M
Citation: Y. Segawa et al., A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group, BR J CANC, 82(1), 2000, pp. 104-111
Authors:
Hiraki, A
Kaneshige, T
Kiura, K
Ueoka, H
Yamane, H
Tanaka, M
Harada, M
Citation: A. Hiraki et al., Loss of HLA haplotype in lung cancer cell lines: Implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer, CLIN CANC R, 5(4), 1999, pp. 933-936
Authors:
Hiraki, A
Ueoka, H
Yoshino, T
Chikamori, KI
Onishi, K
Kiura, K
Bessho, A
Mimoto, J
Date, H
Ando, A
Shimizu, N
Harada, M
Citation: A. Hiraki et al., Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: Diagnosis and treatment, ONCOL REP, 6(1), 1999, pp. 75-80
Authors:
Emori, Y
Kiura, K
Yoshino, T
Notohara, K
Tsuchida, T
Yokoyama, M
Nogami, N
Kataoka, M
Ueoka, H
Harada, M
Citation: Y. Emori et al., Very young patient with peculiar squamous cell carcinoma of the lung, INTERN MED, 38(12), 1999, pp. 979-983
Authors:
Yamane, H
Bessho, A
Kiura, K
Tabata, M
Katayama, Y
Motoda, K
Tsuchida, T
Nogami, N
Hiraki, A
Ueoka, H
Harada, M
Citation: H. Yamane et al., Double high-dose chemotherapy supported by autologous transplantation of peripheral blood stem cells for treatment of an elderly patient with small-cell lung cancer, INTERN MED, 38(11), 1999, pp. 892-895
Authors:
Matsushita, A
Tabata, M
Ueoka, H
Kiura, K
Shibayama, T
Aoe, K
Kohara, H
Harada, M
Citation: A. Matsushita et al., Establishment of a drug sensitivity panel using human lung cancer cell lines, ACT MED OKA, 53(2), 1999, pp. 67-75
Authors:
Ikubo, S
Takigawa, N
Ueoka, H
Kiura, K
Tabata, M
Shibayama, T
Chikamori, M
Aoe, K
Matsushita, A
Harada, M
Citation: S. Ikubo et al., In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines, ANTICANC R, 19(5B), 1999, pp. 3985-3988
Authors:
Bessho, A
Ueoka, H
Kiura, K
Tabata, M
Sunami, K
Katayama, Y
Yamane, H
Hiraki, A
Harada, M
Citation: A. Bessho et al., High-dose ifosfamide, carboplatin and etoposide with autologous peripheralblood progenitor cell transplantation for small-cell lung cancer, ANTICANC R, 19(1B), 1999, pp. 693-698
Authors:
Aoe, K
Kiura, K
Ueoka, H
Tabata, M
Matsumura, T
Chikamori, M
Matsushita, A
Kohara, H
Harada, M
Citation: K. Aoe et al., Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines, ANTICANC R, 19(1A), 1999, pp. 291-299
Authors:
Auperin, A
Arriagada, R
Pignon, JP
Le Pechoux, C
Gregor, A
Stephens, RJ
Kristjansen, PEG
Johnson, BE
Ueoka, H
Wagner, H
Aisner, J
Citation: A. Auperin et al., Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission, N ENG J MED, 341(7), 1999, pp. 476-484
Authors:
Ueoka, H
Tabata, M
Kiura, K
Shibayama, T
Gemba, K
Segawa, Y
Chikamori, K
Yonei, T
Hiraki, S
Harada, M
Citation: H. Ueoka et al., Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study, BR J CANC, 79(5-6), 1999, pp. 984-990
Risultati:
1-23
|